A single dose of a pneumococcal conjugate vaccine (13vPCV, 15vPCV or 20vPCV) is recommended for all non-Indigenous adults at 70 years of age. There is no preference for either 13vPCV, 15vPCV or 20vPCV. It should be noted that 15vPCV and 20vPCV are anticipated to provide benefit against additional serotypes compared to 13vPCV.
Non-Indigenous adults aged ≥70 years who did not receive a dose of a pneumococcal conjugate vaccine at 70 years of age are recommended to receive a single catch-up dose of 13vPCV, 15vPCV or 20vPCV as soon as possible.
Non-Indigenous adults aged ≥70 years who have previously received 23vPPV and have not already received a conjugate vaccine are recommended to receive a single dose of 13vPCV, 15vPCV or 20vPCV at least 12 months after their last 23vPPV dose.
Adults aged ≥70 years with risk conditions for pneumococcal disease are recommended to receive a pneumococcal conjugate vaccine followed by additional doses of 23vPPV, as per the schedule for people with medical risk factors. See Recommendations for people with medical risk factors.
